Skip to Main Content
Mental Health & Behavioral Research, Phase II

The effects of MDMA on social cognition in Borderline Personality Disorder

What is the purpose of this trial?

The purpose of this research study is to investigate the effects of one dose of oral MDMA (3,4-methyl enedioxymethamphetamine) on emotions, experiences, and behavior in adults with Borderline Personality Disorder (BPD). This is not a treatment study and there is no psychotherapy as part of the study. The study may have no direct therapeutic benefits to you, though we hope this study will increase future understanding of MDMA and BPD.

https://redcap.med.yale.edu/surveys/?s=LFEXWYR38EY8Y487

Contact Information

For more information about this study, including how to volunteer, contact Sarah Fineberg

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

  • Last Updated
    04/10/2026
  • Study IRB
    #2000037769